#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3024	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2447	367.1	0	.	n	.	0	C451T	SNP	451	451	C	834	834	T	449	T,C	297,93	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3024	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2447	367.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1567	1567	C	434	C	380	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3024	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2447	367.1	0	HET	.	.	.	C1450T,A	.	1450	1450	C	1833	1833	C	453	C,T,A	327,83,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3024	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2447	367.1	0	HET	.	.	.	C207T	.	207	207	C	590	590	C	433	C,T	295,78	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3024	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2447	367.1	0	HET	.	.	.	C328G	.	328	328	C	711	711	C	420	C,G	290,88	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4798	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3863	372.5	0	.	n	.	0	T695C	SNP	695	695	T	1176	1176	C	359	C,A	310,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4798	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3863	372.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2452	2452	C	461	C,T	395,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4798	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3863	372.5	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3078	3078	T	455	T	394	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4798	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3863	372.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2526	2526	A	474	A	402	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	496	folP	855	855	100.0	folP.l15.c4.ctg.1	1868	79.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1176	1178	AGC	107;107;107	A;G;C	95;96;95	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1134	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3730	91.2	1	SNP	p	S91F	1	.	.	271	273	TTC	753	755	TTC	117;116;116	T,G;T;C	99,1;100;101	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1134	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3730	91.2	1	SNP	p	D95G	1	.	.	283	285	GGC	765	767	GGC	117;116;117	G;G;C	103;101;102	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1134	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3730	91.2	1	SNP	p	G95N	0	.	.	283	285	GGC	765	767	GGC	117;116;117	G;G;C	103;101;102	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	380	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1666	68.5	1	SNP	p	G45D	0	.	.	133	135	GGC	650	652	GGC	110;110;111	G;G;C	92;92;93	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	292	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1328	66.1	0	.	n	.	0	A197.	DEL	197	197	A	746	746	A	106	A	97	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	990	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3327	89.3	1	SNP	p	D86N	0	.	.	256	258	GAC	678	680	GAC	108;107;107	G;A;C	95;92;97	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	990	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3327	89.3	1	SNP	p	S87R	1	.	.	259	261	CGT	681	683	CGT	107;106;106	C;G;T	96;94;91	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	990	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3327	89.3	1	SNP	p	R87W	0	.	.	259	261	CGT	681	683	CGT	107;106;106	C;G;T	96;94;91	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	990	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3327	89.3	1	SNP	p	R87I	0	.	.	259	261	CGT	681	683	CGT	107;106;106	C;G;T	96;94;91	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	990	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3327	89.3	1	SNP	p	S88P	0	.	.	262	264	TCC	684	686	TCC	107;107;107	T;C;C,A	95;98;98,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	848	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2989	85.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1696	1698	GGC	115;115;115	G;G;C	101;100;100	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	750	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2728	82.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1415	1417	GCC	93;93;93	G;C;C	84;80;83	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	750	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2728	82.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1418	1420	ATG	93;93;93	A;T;G	84;82;82	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	750	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2728	82.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1430	1432	ACC	97;98;100	A;C;C	85;84;87	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	750	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2728	82.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1430	1432	ACC	97;98;100	A;C;C	85;84;87	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	750	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2728	82.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1931	1933	ACC	94;94;93	A;C;C	87;85;85	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	750	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2728	82.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1985	1987	GCG	93;93;93	G;C;G	82;81;81	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	750	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2728	82.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1985	1987	GCG	93;93;93	G;C;G	82;81;81	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	750	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2728	82.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2108	2110	GGT	107;108;108	G,A;G;T	86,1;88;87	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	750	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2728	82.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2117	2119	AGC	107;107;107	A;G;C	85;88;87	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	750	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2728	82.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2135	2137	CCG	106;106;108	C,T;C;G	76,1;80;80	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1088	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3414	95.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1790	1792	CCG	121;122;122	C;C;G	98;102;103	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	568	porA	1146	1146	99.91	porA.l6.c4.ctg.1	2104	81.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	749	749	C	109	C	100	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	88	porB1a	984	293	90.91	porB1a.l15.c4.ctg.1	1482	17.5	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1214	1216	AAT	8;8;8	A;A;T	7;8;8	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	88	porB1a	984	293	90.91	porB1a.l15.c4.ctg.1	1482	17.5	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1217	1219	AAT	8;8;8	A;A;T	8;7;8	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	88	porB1a	984	293	90.91	porB1a.l15.c4.ctg.1	1482	17.5	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1241	1243	GCA	6;6;6	G;C;A	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	88	porB1a	984	293	90.91	porB1a.l15.c4.ctg.1	1482	17.5	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1264	1266	GTA	5;5;5	G;T;A	5;4;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	88	porB1a	984	293	90.91	porB1a.l15.c4.ctg.1	1482	17.5	0	.	p	.	0	N237fs	FSHIFT	709	709	A	1273	1273	A	5	A	5	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	542	porB1b	1038	1038	99.81	porB1b.l15.c17.ctg.1	1889	84.6	0	.	p	.	0	G210R	NONSYN	628	630	GGA	1142	1144	AGA	103;106;106	A,C;G;A	81,1;84;84	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	542	porB1b	1038	1038	99.81	porB1b.l15.c17.ctg.1	1889	84.6	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1163	1165	GGT	105;104;104	G;G;T	87;89;87	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	542	porB1b	1038	1038	99.81	porB1b.l15.c17.ctg.1	1889	84.6	1	SNP	p	G120K	1	.	.	358	360	AAG	872	874	AAG	106;104;104	A,C;A;G	87,1;87;86	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	542	porB1b	1038	1038	99.81	porB1b.l15.c17.ctg.1	1889	84.6	1	SNP	p	A121N	1	.	.	361	363	AAC	875	877	AAC	104;105;105	A;A;C	86;86;85	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	542	porB1b	1038	1038	99.81	porB1b.l15.c17.ctg.1	1889	84.6	1	SNP	p	N121D	0	.	.	361	363	AAC	875	877	AAC	104;105;105	A;A;C	86;86;85	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1920	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5228	110.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	250	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1302	57.6	1	SNP	p	V57M	1	.	.	169	171	ATG	692	694	ATG	107;107;107	A;T;G	92;91;91	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
